Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing.

American journal of medical genetics - 6 Jan 1998

Durfy S J, Buchanan T E, Burke W

Abstract excerpt

The identification of genetic mutations linked to breast cancer has made it possible to test for the genetic predisposition to this disease. However, though this test may provide certain benefits, there are also potential risks involved with the testing process, including social and economic considerations. In light of these potential risks, we sought to determine what information individuals are receiving in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to BRCA1 gene
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Mutation

Share to Neoplasm Proteins

Share to Risk Factors

Share to Transcription Factors

Source

Identifiers

PMID: 9450863

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing.PMID 9450863Read ↗

Informed consent for BRCA1 and BRCA2 testing: what clinicians should know about the process and content.Semantic proximity Read ↗

Not all information is equally important: informed consent to genetic testing for hereditary cancer.Semantic proximity Read ↗

Are practicing and future physicians prepared to obtain informed consent? The case of genetic testing for susceptibility to breast cancer.Semantic proximity Read ↗

Defining the Critical Components of Informed Consent for Genetic TestingSemantic proximity Read ↗

Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.Semantic proximity Read ↗

Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre-test counseling for hereditary cancer risk.Semantic proximity Read ↗

"Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing.Semantic proximity Read ↗

“Cancer in the family” and genetic testing: implications for life insuranceSemantic proximity Read ↗

Genetic testing for susceptibility to breast cancer: findings from women's focus groups.Semantic proximity Read ↗

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.Semantic proximity Read ↗

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.Semantic proximity Read ↗

Decision making and decision support for hereditary breast-ovarian cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.